Limited Competition for Competitive Revision Applications to Accelerate and Enhance Collaborative Translational Science (UL1)
The summary for the Limited Competition for Competitive Revision Applications to Accelerate and Enhance Collaborative Translational Science (UL1) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition for Competitive Revision Applications to Accelerate and Enhance Collaborative Translational Science (UL1): The NCRR announces that competitive revision applications to fund collaborative translational science projects with clinical significance across multiple Clinical and Translational Science Award (CTSA) institutions are encouraged. These competitive revisions are limited to the UL1 component of a CTSA award.
Federal Grant Title: | Limited Competition for Competitive Revision Applications to Accelerate and Enhance Collaborative Translational Science (UL1) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-RR-11-004 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.389 |
CFDA Descriptions: | National Center for Research Resources |
Current Application Deadline: | Jun 28, 2011 |
Original Application Deadline: | May 26, 2011 |
Posted Date: | Mar 25, 2011 |
Creation Date: | Jun 14, 2011 |
Archive Date: | Jul 28, 2011 |
Total Program Funding: | $2,000,000 |
Maximum Federal Grant Award: | $500,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 4 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are not allowed.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Limited Competition: Competitive Revision for Technology Development within Biomedical Tec...
- • Centers of Biomedical Research Excellence (COBRE) (P20)
- • Instrument Development for Biomedical Applications (R21)
- • Limited Competition: Institutional Development Award (IDeA) Program Infrastructure for Cli...
- • High-End Instrumentation Grant Program (S10)
- • NCRR Science Education Partnership Award (SEPA) [R25]
- • Planning Grants for Institutional Clinical and Translational Science Awards
- • Institutional Clinical and Translational Science Award
- More Grants from the National Institutes of Health
- • Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
- • Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
- • Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
- • NINDS Program Project Grant (P01 Clinical Trial Optional)
- • Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...